Medtronic unveiled a next-generation version of its superDimension nav...
SQZ Biotech (SQZ) has announced a partnership with Roche to develop a ...
Of the three major indications within hematological cancer, namely leu...
Singapore: With more than 1,300 deaths reported every day, cancer in I...
He is a collaborative science chair at inStem and NCBS, Bangalore, and...
The rising breast cancer incidence among women is a cause for concern....
Merck and The University of Texas MD Anderson Cancer Center has announ...
GE Healthcare has become the first company with a low dose computed to...
Illumina has announced its collaboration with Merck to develop a unive...
Pharmaceutical Product Development (PPD) has announced that it has ach...
Novartis has announced that the European Commission has approved Faryd...
Roche has announced that the European Commission (EU) has approved Ava...
IIT-Delhi graduate, Mr Rohit Bhargava, currently a professor at the Un...
Cancer patients from Karnataka and anywhere else in India can now rece...
As per the latest statement issed by MSD India on April, 21, the human...
Simon Fraser University PhD alumna Ms Maryam Sadeghi has developed Mol...
Novartis has announced that the European Commission has approved Odomz...
Roche's atezolizumab is poised to become a major bladder cancer therap...